Abstract | Keywords | Export | Availability | Bookmark

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The thesis is a response to the recent decisions of the German Federal Court of Justice on the patentability requirements of selection inventions, namely, the Olanzapine and Escitalopram decisions.

Drugs --- Patent laws and legislation --- Conflict of laws --- Drug development. --- Olanzapine. --- Citalopram. --- Patents --- Celexa --- Citalopram Hydrobromide --- Cytalopram --- Escitalopram --- Escitalopram Oxalate --- Lexapro --- Lu-10-171 --- Seropram --- Lu10171 --- OLZ (Drug) --- Antipsychotic drugs --- Dopamine --- Pirenzepine --- Serotonin --- Development of drugs --- New drug development --- Pharmacology --- Pharmacy --- Choice of law --- Intermunicipal law --- International law, Private --- International private law --- Private international law --- Law --- Legal polycentricity --- Law, Patent --- Scientific property --- Industrial laws and legislation --- Industrial property --- Trade regulation --- Copyright --- Antagonists --- Development --- Civil law --- Law and legislation --- Markenrecht --- Urheberrecht / Gewerblicher Rechtsschutz und Medienrecht --- Gewerblicher Rechtsschutz